Skip to main content
Livermore
Livermore
ZHEN

Adaptimmune Therapeutics PLC

ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001621227

No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Adaptimmune Therapeutics PLC as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
81
+6 vs. Q2 2024
Shares held
151.7M
−2.01M (−1.3%) vs. Q2 2024
Total value
$144.1M
−$5.70M (−3.8%) vs. Q2 2024
New holders
18
21 more added
Sold out
12
15 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 81 institutions
Q1 2021: 84 institutionsQ2 2021: 82 institutionsQ3 2021: 92 institutionsQ4 2021: 85 institutionsQ1 2022: 80 institutionsQ2 2022: 77 institutionsQ3 2022: 68 institutionsQ4 2022: 69 institutionsQ1 2023: 65 institutionsQ2 2023: 89 institutionsQ3 2023: 79 institutionsQ4 2023: 79 institutionsQ1 2024: 80 institutionsQ2 2024: 76 institutionsQ3 2024: 81 institutionsQ4 2024: 80 institutionsQ1 2025: 67 institutionsQ2 2025: 65 institutionsQ3 2025: 55 institutionsQ4 2025: 10 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ3 2024: $144.1M
Q1 2021: $623.8MQ2 2021: $475.7MQ3 2021: $577.3MQ4 2021: $425.9MQ1 2022: $229.2MQ2 2022: $195.1MQ3 2022: $122.4MQ4 2022: $166.3MQ1 2023: $126.4MQ2 2023: $133.9MQ3 2023: $115.7MQ4 2023: $113.9MQ1 2024: $256.1MQ2 2024: $150.0MQ3 2024: $144.1MQ4 2024: $67.0MQ1 2025: $22.9MQ2 2025: $27.7MQ3 2025: $5.47MQ4 2025: $79.7KQ1 2026: $72Q2 2026: $0
Institutions holding ADAPY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$72
Q4 202510$79.7K
Q3 202555$5.47M
Q2 202565$27.7M
Q1 202567$22.9M
Q4 202480$67.0M
Q3 202481$144.1M
Q2 202476$150.0M
Q1 202480$256.1M
Q4 202379$113.9M
Q3 202379$115.7M
Q2 202389$133.9M
Q1 202365$126.4M
Q4 202269$166.3M
Q3 202268$122.4M
Q2 202277$195.1M
Q1 202280$229.2M
Q4 202185$425.9M
Q3 202192$577.3M
Q2 202182$475.7M
Q1 202184$623.8M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q2 2024.

Institutions holding ADAPY in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC1,052$00.00%+1,052New
Danske Bank A/S1$10.00%+1New
TD Waterhouse Canada Inc.14$130.00%+14New
Northwestern Mutual Wealth Management Co69$660.00%+69New
Investors Research Corp100$950.00%00.0%Unchanged
BNP Paribas Arbitrage, SA213$2020.00%00.0%Unchanged
HighMark Wealth Management LLC287$2730.00%00.0%Unchanged
Carmichael Hill & Associates, Inc.525$4990.00%00.0%Unchanged
Bryn Mawr Trust Co604$5740.00%+604New
Federation des caisses Desjardins du Quebec755$7170.00%−30−3.8%Reduced
Plante Moran Financial Advisors, LLC925$8790.00%+925New
Sandy Spring Bank1,050$9980.00%00.0%Unchanged
UBS Group AG1,817$1.73K0.00%00.0%Unchanged
CIBC Private Wealth Group, LLC3,023$2.87K0.00%00.0%Unchanged
IFP Advisors, Inc3,023$2.87K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,665$4.43K0.00%+4,665New
Lindbrook Capital, LLC4,847$4.61K0.00%+237+5.1%Added
Global Retirement Partners, LLC6,000$5.70K0.00%00.0%Unchanged
Signaturefd, LLC6,620$6.29K0.00%+6,620New
Parallel Advisors, LLC7,183$6.83K0.00%+6,933+2,773.2%Added
X-Square Capital, LLC11,180$10.0K0.00%−12−0.1%Reduced
Wealth Enhancement Advisory Services, LLC10,816$10.3K0.00%−24,286−69.2%Reduced
Greenleaf Trust11,856$11.3K0.00%+11,856New
Two Sigma Advisers, LP11,948$11.4K0.00%−21,389−64.2%Reduced
Quadrant Capital Group LLC12,280$11.7K0.00%+9,062+281.6%Added
Graham Capital Management, L.P.12,592$12.0K0.00%+12,592New
Commonwealth Equity Services, LLC13,433$13.0K0.00%−6,762−33.5%Reduced
Advisor Group Holdings, Inc.15,258$14.5K0.00%00.0%Unchanged
Ballentine Partners, LLC16,758$15.9K0.00%+16,758New
Rhumbline Advisers19,160$18.2K0.00%+2,439+14.6%Added
Newman Dignan & Sheerar, Inc.27,957$20.6K0.00%+27,957New
Hunter Associates Investment Management LLC23,000$22.0K0.00%00.0%Unchanged
Prosperity Wealth Management, Inc.24,620$23.4K0.01%−2,000−7.5%Reduced
HSBC Holdings PLC26,064$24.5K0.00%00.0%Unchanged
Fullcircle Wealth LLC35,000$25.8K0.01%+35,000New
IFG Advisory, LLC27,500$26.1K0.00%+27,500New
Stifel Financial Corp27,619$26.2K0.00%00.0%Unchanged
Simon Quick Advisors, LLC30,452$28.9K0.00%+452+1.5%Added
DLK Investment Management, LLC30,512$29.0K0.01%00.0%Unchanged
Janney Montgomery Scott LLC30,000$29.0K0.00%00.0%Unchanged
CSS LLC30,702$29.2K0.00%00.0%Unchanged
Columbia Advisory Partners LLC31,420$29.9K0.03%+3,333+11.9%Added
Invesco Ltd.34,809$33.1K0.00%+66+0.2%Added
Oppenheimer & Co Inc36,275$34.5K0.00%−3,023−7.7%Reduced
Vontobel Holding Ltd.43,000$40.9K0.00%+30,000+230.8%Added
Palisades Investment Partners, LLC43,455$41.3K0.02%+43,455New
Group One Trading, L.P.48,370$46.0K0.00%+14,333+42.1%Added
Barclays PLC50,061$47.6K0.00%00.0%Unchanged
Northern Trust Corp51,333$48.8K0.00%−528−1.0%Reduced
Two Sigma Investments, LP57,201$54.4K0.00%+57,201New
Wells Fargo & Company66,821$63.5K0.00%+3,149+4.9%Added
Captrust Financial Advisors83,041$78.9K0.00%00.0%Unchanged
Goldman Sachs Group Inc84,410$80.2K0.00%+68,291+423.7%Added
LPL Financial LLC88,856$84.4K0.00%−110,000−55.3%Reduced
Gsa Capital Partners LLP99,662$95.0K0.01%+99,662New
Virtu Financial LLC101,008$96.0K0.01%+21,769+27.5%Added
Geode Capital Management, LLC139,801$132.9K0.00%+21,892+18.6%Added
Jane Street Group, LLC174,157$165.5K0.00%+98,581+130.4%Added
Susquehanna International Group, LLP189,472$180.1K0.00%−52,672−21.8%Reduced
Key Client Fiduciary Advisors, LLC255,359$242.7K0.11%−8,630−3.3%Reduced
BlackRock, Inc.283,626$269.6K0.00%+283,626New
DAFNA Capital Management LLC341,064$324.1K0.08%00.0%Unchanged
State Street Corp396,792$377.1K0.00%+5,891+1.5%Added
Rathbone Brothers plc432,818$411.4K0.00%00.0%Unchanged
Marshall Wace, LLP522,608$496.5K0.00%+377,728+260.7%Added
Millennium Management LLC715,350$679.9K0.00%−64,265−8.2%Reduced
Redmile Group, LLC715,607$680.1K0.04%00.0%Unchanged
JPMorgan Chase & Co1,045,533$993.7K0.00%+8,295+0.8%Added
Renaissance Technologies LLC1,656,575$1.57M0.00%−129,766−7.3%Reduced
Morgan Stanley1,699,025$1.61M0.00%+1,258,193+285.4%Added
FMR LLC1,740,900$1.65M0.00%+50,419+3.0%Added
Rock Springs Capital Management LP2,425,468$2.31M0.07%00.0%Unchanged
Bank of America Corp4,653,325$4.42M0.00%00.0%Unchanged
MPM Oncology Impact Management LP5,095,912$4.84M0.73%00.0%Unchanged
MPM Asset Management LLC5,555,461$5.28M3.63%00.0%Unchanged
PFM Health Sciences, LP10,000,787$9.50M0.55%−519,444−4.9%Reduced
Long Focus Capital Management, LLC13,299,890$12.6M1.12%+953,473+7.7%Added
Baillie Gifford & Co16,775,860$15.9M0.01%+1,626,657+10.7%Added
NEA Management Company, LLC17,079,778$16.2M0.88%00.0%Unchanged
EcoR1 Capital, LLC27,404,070$26.0M0.89%00.0%Unchanged
Matrix Capital Management Company, LP37,681,515$35.8M1.71%−1,292,670−3.3%Reduced
Baker Bros. Advisors LP0$00.00%−2,343,695−100.0%Sold out
Tang Capital Management LLC0$00.00%−1,743,619−100.0%Sold out
Acuitas Investments, LLC0$00.00%−541,201−100.0%Sold out
Citadel Advisors LLC0$00.00%−142,891−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−98,589−100.0%Sold out
Main Street Financial Solutions, LLC0$00.00%−31,190−100.0%Sold out
JTC Employer Solutions Trusteee Ltd0$00.00%−26,156−100.0%Sold out
XTX Topco Ltd0$00.00%−12,399−100.0%Sold out
Raymond James & Associates0$00.00%−10,218−100.0%Sold out
Wetzel Investment Advisors, Inc.0$00.00%−6,000−100.0%Sold out
Baader Bank INC0$00.00%−10,287−100.0%Sold out
National Bank of Canada0$00.00%−10−100.0%Sold out
BlackRock Inc.––––Not filed